Meili  Li

Changchun Institute of Biological Products Co., Ltd., Changchun, 130012, Jilin, China
Author    Correspondence author
Journal of Vaccine Research, 2024, Vol. 14, No. 3   
Received: 10 May, 2024    Accepted: 12 Jun., 2024    Published: 25 Jun., 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

The latest advancements in mRNA vaccine technology have ushered in a new era for breast cancer treatment, offering a promising alternative to traditional therapies. This study explores the current trends and future prospects of mRNA vaccines in breast cancer treatment, detailing their mechanisms, efficacy, and safety profiles. It highlights significant preclinical studies and clinical trials demonstrating the potential of mRNA vaccines to induce robust immune responses and achieve tumor regression. Innovations such as nanoparticle delivery systems and advanced mRNA modifications have enhanced the stability and effectiveness of these vaccines. Furthermore, the integration of mRNA vaccines with other therapies, including immunotherapy and chemotherapy, has shown synergistic effects, improving patient outcomes. However, to fully realize the potential of mRNA vaccines, challenges related to technology, logistics, and biological barriers must be addressed. Personalized mRNA vaccines and emerging technologies pave the way for more precise and effective breast cancer treatments. This study emphasizes the transformative potential of mRNA vaccines in oncology and highlights the importance of ongoing research efforts to overcome current challenges and expand their clinical applications.

mRNA vaccines; Breast cancer; Cancer immunotherapy; Personalized medicine; Clinical trials; Emerging technologies